- Home
- SGHT
SGHT
Sight Sciences Inc.
as of 12-31-2025 3:39pm EST
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | MENLO PARK |
| Market Cap: | 193.2M | IPO Year: | 2021 |
| Target Price: | $7.66 | AVG Volume (30 days): | 262.9K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.89 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.03 - $9.24 | Next Earning Date: | 11-06-2025 |
| Revenue: | $76,052,000 | Revenue Growth: | -4.39% |
| Revenue Growth (this year): | -1.48% | Revenue Growth (next year): | 12.07% |
AI-Powered SGHT Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Sight Sciences Inc. (SGHT)
Director, 10% Owner
Avg Cost/Share
$8.31
Shares
13,958
Total Value
$115,963.06
Owned After
1,391,922
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$8.25
Shares
2,518
Total Value
$20,773.50
Owned After
158,845
SEC Form 4
EVP, Operations & R&D
Avg Cost/Share
$7.06
Shares
14,418
Total Value
$101,791.08
Owned After
170,831
SEC Form 4
EVP, Operations & R&D
Avg Cost/Share
$3.37
Shares
591
Total Value
$1,991.67
Owned After
170,831
SEC Form 4
Chief Legal Officer
Avg Cost/Share
$3.27
Shares
9,731
Total Value
$31,820.37
Owned After
256,590
SEC Form 4
Chief Technology Officer
Avg Cost/Share
$3.27
Shares
6,033
Total Value
$19,727.91
Owned After
1,864,992
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Encrantz Staffan | SGHT | Director, 10% Owner | Dec 16, 2025 | Buy | $8.31 | 13,958 | $115,963.06 | 1,391,922 | |
| Rodberg James | SGHT | Chief Financial Officer | Dec 2, 2025 | Sell | $8.25 | 2,518 | $20,773.50 | 158,845 | |
| Taylor Brenton | SGHT | EVP, Operations & R&D | Nov 17, 2025 | Sell | $7.06 | 14,418 | $101,791.08 | 170,831 | |
| Taylor Brenton | SGHT | EVP, Operations & R&D | Oct 6, 2025 | Sell | $3.37 | 591 | $1,991.67 | 170,831 | |
| HAYDEN JEREMY B. | SGHT | Chief Legal Officer | Oct 3, 2025 | Sell | $3.27 | 9,731 | $31,820.37 | 256,590 | |
| Badawi David | SGHT | Chief Technology Officer | Oct 3, 2025 | Sell | $3.27 | 6,033 | $19,727.91 | 1,864,992 |
Compare SGHT vs Leading Stocks
See how SGHT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SGHT Sight Sciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.